InterCure Ltd.
INCR
$1.60
$0.053.23%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -36.30% | -33.71% | -1.49% | 10.10% | 19.83% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -36.30% | -33.71% | -1.49% | 10.10% | 19.83% |
| Cost of Revenue | -15.08% | -16.08% | 25.54% | 29.99% | 33.91% |
| Gross Profit | -63.83% | -59.57% | -32.24% | -12.63% | 5.45% |
| SG&A Expenses | -21.97% | -31.46% | -3.51% | 24.75% | 15.60% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -95.69% | 121.50% | -41.33% | 317.96% | 360.69% |
| Total Operating Expenses | -38.37% | -13.80% | 14.54% | 34.93% | 58.08% |
| Operating Income | 54.69% | -137.12% | -70.29% | -73.17% | -204.56% |
| Income Before Tax | -232.99% | -341.02% | -98.26% | -91.73% | -408.83% |
| Income Tax Expenses | 112.72% | -51.53% | -153.06% | -67.69% | -326.15% |
| Earnings from Continuing Operations | -685.52% | -467.83% | -77.95% | -99.43% | 256.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -95.90% | 112.69% | 554.43% | 108.32% | 9,709.18% |
| Net Income | -459.01% | -519.32% | -71.39% | -98.55% | 351.83% |
| EBIT | 54.69% | -137.12% | -70.29% | -73.17% | -204.56% |
| EBITDA | 68.34% | -122.84% | -59.27% | -63.16% | -195.84% |
| EPS Basic | -463.70% | -524.63% | -74.40% | -98.82% | 236.71% |
| Normalized Basic EPS | 20.75% | -202.15% | -- | -91.60% | -230.22% |
| EPS Diluted | -463.89% | -524.63% | -73.65% | -98.76% | 228.27% |
| Normalized Diluted EPS | 20.30% | -202.15% | -- | -91.13% | -229.48% |
| Average Basic Shares Outstanding | -1.31% | -1.19% | 11.62% | 21.61% | 84.42% |
| Average Diluted Shares Outstanding | -1.78% | -1.19% | 8.43% | 15.21% | 85.30% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |